Wegovy is a prescription medication containing semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist licensed for chronic weight management in adults with obesity or overweight with weight-related comorbidities, as per NICE Technology Appraisal 875
Duration typically extends eight to twelve weeks or longer for chronic conditions
It is often associated with other symptoms such as sleep disturbances, mood issues, and cognitive difficulties
doi:10.1016/S0140-6736(06)69705-5 104
Even modest weight loss can help restore regular menstrual cycles and ovulation in some women
By enhancing that signal, semaglutide improves glucose control, slows how quickly the stomach empties, and helps you feel full sooner and longer which is why it supports medical weight loss